Gülsan Türköz Sucak

Addition of thalidomide to oral melphalan/prednisone in patients with multiple myeloma not eligible for transplantation: results of a randomized trial from the Turkish Myeloma Study Group

Meral Beksaç, Rauf Haznedar, Tülin Firatli‐Tuglular et al. · European Journal Of Haematology · 2010 · 143 citations

Prognostic factors in critically ill cancer patients admitted to the intensive care unit

Gülbin Aygencel, Melda Türkoğlu, Gülsan Türköz Sucak et al. · Journal of Critical Care · 2014 · 99 citations

Critical Care Management, Prognostic Factors, Critical Care Medicine +10

Impact of conditioning with TBI in adult patients with T-cell ALL who receive a myeloablative allogeneic stem cell transplantation: a report from the acute leukemia working party of EBMT

Xavier Cahu, Myriam Labopin, Sebastian Giebel et al. · Bone Marrow Transplantation · 2015 · 89 citations

Cell Therapy, T-cell All, Transplantation +10

Value of 18F-fluorodeoxyglucose uptake in positron emission tomography/computed tomography in predicting survival in multiple myeloma

Rauf Haznedar, Şahika Zeynep Akı, Ümit Özgür Akdemir et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2011 · 86 citations

Positron Emission Tomography, Hematological Malignancy, 18F-fluorodeoxyglucose Uptake +10

Tumor-associated macrophages as a prognostic parameter in multiple myeloma

Elif Suyanı, Gülsan Türköz Sucak, Nalân Akyürek et al. · Annals of Hematology · 2013 · 85 citations

Hematological Malignancy, Medicine, Immunology +4